Repare Therapeutics Inc.: operating lease payments

What this measure means

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Exact concept: us-gaap:OperatingLeasePayments. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Repare Therapeutics Inc.: total assets
• Repare Therapeutics Inc.: total liabilities
• Repare Therapeutics Inc.: stockholders equity
• Repare Therapeutics Inc.: cash and cash equivalents
• Repare Therapeutics Inc.: net income or loss
• Repare Therapeutics Inc.: operating cash flow
• Repare Therapeutics Inc.: capital expenditure payments
• Repare Therapeutics Inc.: financing cash flow
• Repare Therapeutics Inc.: investing cash flow
• Repare Therapeutics Inc.: retained earnings or deficit
• Repare Therapeutics Inc.: basic weighted-average shares
• Repare Therapeutics Inc.: diluted weighted-average shares
• Repare Therapeutics Inc.: basic earnings per share
• Repare Therapeutics Inc.: diluted earnings per share
• Repare Therapeutics Inc.: income tax expense or benefit
• Repare Therapeutics Inc.: net property, plant and equipment
• Repare Therapeutics Inc.: share-based compensation expense
• Repare Therapeutics Inc.: operating income or loss
• Repare Therapeutics Inc.: current assets
• Repare Therapeutics Inc.: current liabilities
• Repare Therapeutics Inc.: current accounts payable
• Repare Therapeutics Inc.: operating expenses
• Repare Therapeutics Inc.: research and development expense
• Repare Therapeutics Inc.: common shares outstanding
• Repare Therapeutics Inc.: cash including restricted cash
• Repare Therapeutics Inc.: accumulated other comprehensive income or loss
• Repare Therapeutics Inc.: operating lease right-of-use asset
• Repare Therapeutics Inc.: operating lease liability
• Repare Therapeutics Inc.: gross property, plant and equipment
• Repare Therapeutics Inc.: accumulated depreciation on property, plant and equipment
• Repare Therapeutics Inc.: other noncurrent assets
• Repare Therapeutics Inc.: current contract liabilities
• Repare Therapeutics Inc.: pre-tax income or loss from continuing operations
• Repare Therapeutics Inc.: profit or loss including noncontrolling interests
• Repare Therapeutics Inc.: comprehensive income or loss
• Repare Therapeutics Inc.: net income available to common stockholders
• Repare Therapeutics Inc.: general and administrative expense
• Repare Therapeutics Inc.: depreciation expense
• Repare Therapeutics Inc.: nonoperating income or expense
• Repare Therapeutics Inc.: interest paid, net
• Repare Therapeutics Inc.: change in accounts payable

Inspect the source

Entity

Repare Therapeutics Inc. / CIK 0001808158

Captured

2026-09-21T17:28:08.273Z

SEC response SHA-256

5b4ad4b22a3a13ec8dc2fdffd62cba7c92ae43dbdaef148f3fb71bd1d83755c6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001808158.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))